A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback